← Leaderboards
Peter Lobo
University Of Virginia Charlottesville
$3,360,926
Attributed
$4,417,194
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $704.7K · FY2009–21$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,417,194 · 4
By mechanism
R01$3,565,755 · 2
R21$851,439 · 2
Top collaborators
- Mark Douglas Okusa5 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Prabhakara P Reddi$4,076,398
- Mark Douglas Okusa$24,807,098
- Raghavendra G Mirmira$22,841,626
- Jerry L. Nadler$10,120,845
- Joel M. Linden$14,399,863
Others in their field
Top investigators on “Immunoglobulin M”
- Margaret A Shipp · Dana-Farber Cancer Institute$32,940,111
- Barton F Haynes · Duke University$17,745,734
- Edward T. Ryan · Massachusetts General Hospital$12,917,925
- Andrea Cerutti · Weill Medical College Of Cornell Univ$12,245,057
- Nicole Baumgarth · Johns Hopkins University$11,358,259
- Robert F Garry · Scripps Research Institute, The$10,602,778
Research focus
Immunoglobulin MAnti-IgmMediatingCellsInflammatoryInflammatory ResponseAutoantibodiesProductionIn VivoKidneyB-LymphocytesInflammationChemotaxisPlasmaCell PhysiologyImmuneMorbidity - Disease RateIschemiaEventMacrophageInjuryAcute Renal Failure With Renal Papillary NecrosisIntravenousProtective Effect
Grant awards (13)
CpG and B cells, pretreated ex-vivo with natural IgM, protect against renal IRI$363,375
R01 · FY2021 · DK · contact PI
CpG and B cells, pretreated ex-vivo with natural IgM, protect against renal IRI$363,375
R01 · FY2020 · DK · contact PI
CpG and B cells, pretreated ex-vivo with natural IgM, protect against renal IRI$363,375
R01 · FY2019 · DK · contact PI
CpG and B cells, pretreated ex-vivo with natural IgM, protect against renal IRI$363,094
R01 · FY2018 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$399,137
R01 · FY2014 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$386,639
R01 · FY2013 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$404,439
R01 · FY2012 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$406,999
R01 · FY2011 · DK · contact PI
Naturally Occurring IgM Anti-Leucocyte Autoantibodies Protect Against Renal IRI$515,322
R01 · FY2010 · DK · contact PI
IgM Antileucocyte Autoantibodies Inhibit Kidney Allograft Rejections$189,375
R21 · FY2010 · DK · contact PI
IgM Antileucocyte Autoantibodies Inhibit Kidney Allograft Rejections$224,160
R21 · FY2009 · DK · contact PI
Natural IgM antilymphocyte autoantibodies inhibit HIV-1$222,000
R21 · FY2003 · AI
Natural IgM antilymphocyte autoantibodies inhibit HIV-1$215,904
R21 · FY2002 · AI